Innovation in Clinical Trials Management Session Slated for Biotech 2001 in Atlantic City

Apr 11, 2001, 01:00 ET from Biotechnology Council of N.J., Inc. from ,Pa Biotechnology Association

    TRENTON, N.J., April 11 /PRNewswire/ -- Biotech 2001: Opportunities in the
 Nation's Pharmaceutical Center will feature a session, entitled Innovation in
 Clinical Trials Management, which will examine how new technologies, including
 the Internet, are impacting the design and management of clinical trials.  The
 joint Symposium, presented by the Biotechnology Council of New Jersey (BCNJ)
 and the Pennsylvania Biotechnology Association (PABIOTECH), will take place on
 April 23-24, 2001 at the Atlantic City Convention Center and the Atlantic City
 Sheraton.
     The Clinical Trials session, moderated by Leonard Jacob, M.D., Ph.D.,
 Chairman and CEO of Inkine Pharmaceuticals, will feature a panel of prominent
 speakers including Anup Dam, CEO, Stat-Trade, Inc.; Leslie D. Michelson, CEO &
 Co-Founder, Acurian, Inc.; and John Kurtz, Senior Vice President, Data
 Management and Biometrics, Omnicare Clinical Research.  The panel will examine
 the dramatic developments in discovery and drug development and the clinical
 trial process.
     This year's Symposium also includes focus panels such as Gene Therapy and
 the Future of Medicine; The Genomics Revolution; Finding an International
 Pharmaceutical Partner; Capital Formation Outlook; Women's Health and Overview
 of the Industry.  Other topics include financial disclosure; hiring and
 retaining critical scientists and executives; deal making; and a round-up of
 what's in the pipeline in research institutions in our respective states.
     Sponsors to date include Aventis Pharmaceuticals, Ballard Spahr Andrews &
 Ingersoll, Ben Franklin Technology Partners, Biotechnology Industry
 Organization, Brettler Financial Group, BTG International, Inc., Centocor,
 Inc., Cephalon, Inc., Dechert, Delsys Pharmaceutical Corporation, Ernst &
 Young, GlaxoSmithKline, Greater Philadelphia First, Government of Canada,
 Harkins Cunningham, Imperial Bank, Kirkpatrick & Lockhart LLP, Medarex, Inc.,
 NEOSE Technologies, Inc., New Jersey Economic Development Authority, Ortho
 Biotech, Inc., PECO Energy Company, Pennsylvania Department of Community and
 Economic Development, Pharmacia, Inc, Pittsburgh Technology Council,
 Pittsburgh Regional Alliance, PSE&G, QED Technologies, Inc., S.R. One,
 Limited, University of Pittsburgh, and Wyeth Ayerst Laboratories.
     For more information about the program or to register, contact Symposium
 Headquarters at 800-231-0022.  Program details can also be found at
 www.newjerseybiotech.org and www.pabiotech.org.
     The Biotechnology Council of New Jersey and the Pennsylvania Biotechnology
 Association represent the biotechnology communities in their respective
 states.  Through their education and advocacy efforts, both associations work
 to advance biotechnology in the region.
 
 

SOURCE Biotechnology Council of N.J., Inc.; Pa Biotechnology Association
    TRENTON, N.J., April 11 /PRNewswire/ -- Biotech 2001: Opportunities in the
 Nation's Pharmaceutical Center will feature a session, entitled Innovation in
 Clinical Trials Management, which will examine how new technologies, including
 the Internet, are impacting the design and management of clinical trials.  The
 joint Symposium, presented by the Biotechnology Council of New Jersey (BCNJ)
 and the Pennsylvania Biotechnology Association (PABIOTECH), will take place on
 April 23-24, 2001 at the Atlantic City Convention Center and the Atlantic City
 Sheraton.
     The Clinical Trials session, moderated by Leonard Jacob, M.D., Ph.D.,
 Chairman and CEO of Inkine Pharmaceuticals, will feature a panel of prominent
 speakers including Anup Dam, CEO, Stat-Trade, Inc.; Leslie D. Michelson, CEO &
 Co-Founder, Acurian, Inc.; and John Kurtz, Senior Vice President, Data
 Management and Biometrics, Omnicare Clinical Research.  The panel will examine
 the dramatic developments in discovery and drug development and the clinical
 trial process.
     This year's Symposium also includes focus panels such as Gene Therapy and
 the Future of Medicine; The Genomics Revolution; Finding an International
 Pharmaceutical Partner; Capital Formation Outlook; Women's Health and Overview
 of the Industry.  Other topics include financial disclosure; hiring and
 retaining critical scientists and executives; deal making; and a round-up of
 what's in the pipeline in research institutions in our respective states.
     Sponsors to date include Aventis Pharmaceuticals, Ballard Spahr Andrews &
 Ingersoll, Ben Franklin Technology Partners, Biotechnology Industry
 Organization, Brettler Financial Group, BTG International, Inc., Centocor,
 Inc., Cephalon, Inc., Dechert, Delsys Pharmaceutical Corporation, Ernst &
 Young, GlaxoSmithKline, Greater Philadelphia First, Government of Canada,
 Harkins Cunningham, Imperial Bank, Kirkpatrick & Lockhart LLP, Medarex, Inc.,
 NEOSE Technologies, Inc., New Jersey Economic Development Authority, Ortho
 Biotech, Inc., PECO Energy Company, Pennsylvania Department of Community and
 Economic Development, Pharmacia, Inc, Pittsburgh Technology Council,
 Pittsburgh Regional Alliance, PSE&G, QED Technologies, Inc., S.R. One,
 Limited, University of Pittsburgh, and Wyeth Ayerst Laboratories.
     For more information about the program or to register, contact Symposium
 Headquarters at 800-231-0022.  Program details can also be found at
 www.newjerseybiotech.org and www.pabiotech.org.
     The Biotechnology Council of New Jersey and the Pennsylvania Biotechnology
 Association represent the biotechnology communities in their respective
 states.  Through their education and advocacy efforts, both associations work
 to advance biotechnology in the region.
 
 SOURCE  Biotechnology Council of N.J., Inc.; Pa Biotechnology Association